FDA inspection
Laboratoire Icare: FDA inspection ending Jun 23, 2023
FDA inspection 1270830 · Voluntary Action Indicated (VAI) · Saint-Beauzire
Key facts
| Inspection ID | 1270830 |
|---|---|
| Firm | Laboratoire Icare |
| FEI number | 3008220949 |
| Address | Clermont Limagne Rue Emile Duclaux Biopole |
| City | Saint-Beauzire |
| Country | France |
| Fiscal year | 2023 |
| Inspection end date | Jun 23, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data